Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis
- Publisher
- THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
- Language
- 영어
- ISSN
- 1758-8340
- Citation Volume
- 12
- Citation Number
- 0
- Citation Start Page
- 0
- Citation End Page
- 0
-
Appears in Collections:
- Medicine > Medicine
- Authorize & License
-
- Files in This Item:
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.